Pentelute Lab MIT | A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins
The Pentelute Lab aims to invent new chemistry for the efficient and selective modification of proteins, to ‘hijack’ these biological machines for efficient drug delivery into cells and to create new machines to rapidly and efficiently manufacture peptides and proteins.
Pentelute Lab, Chemistry, MIT, Chemistry Department, Boston, Cambridge, Biology, Peptides, Peptide, Proteins, Science, Rapid, Brad Pentelute, Brad,
17431
portfolio_page-template-default,single,single-portfolio_page,postid-17431,ajax_fade,page_not_loaded,,paspartu_enabled,paspartu_on_top_fixed,paspartu_on_bottom_fixed,qode_grid_1200,qode_popup_menu_push_text_top,qode-theme-ver-16.2.1,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.4.7,vc_responsive
 

A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins

A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins

Nature Chemistryvolume 11, pages78–85 (2019) Daniel T. Cohen, Chi Zhang, Colin M. Fadzen, Alexander J. Mijalis, Liana Hie, Kenneth D. Johnson, Zachary Shriver, Obadiah Plante, Scott J. Miller, Stephen L. Buchwald & Bradley L. Pentelute

Abstract

Conjugates between proteins and small molecules enable access to a vast chemical space that is not achievable with either type of molecule alone; however, the paucity of specific reactions capable of functionalizing proteins and natural products presents a formidable challenge for preparing conjugates. Here we report a strategy for conjugating electron-rich (hetero)arenes to polypeptides and proteins. Our bioconjugation technique exploits the electrophilic reactivity of an oxidized selenocysteine residue in polypeptides and proteins, and the electron-rich character of certain small molecules to provide bioconjugates in excellent yields under mild conditions. This conjugation chemistry enabled the synthesis of peptide–vancomycin conjugates without the prefunctionalization of vancomycin. These conjugates have an enhanced in vitro potency for resistant Gram-positive and Gram-negative pathogens. Additionally, we show that a 6 kDa affibody protein and a 150 kDa immunoglobulin-G antibody could be modified without diminishing bioactivity.

Category
2019, Publications